Celldex Therapeutics, Inc.

CLDX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$28,356$34,814$29,429$39,143
Short-Term Investments$696,925$386,884$275,523$369,107
Receivables$700$4,528$347$172
Inventory$0$0$0$0
Other Curr. Assets$21,178$5,467$12,394$2,417
Total Curr. Assets$747,159$431,693$317,693$410,839
Property Plant & Equip (Net)$8,244$6,637$7,748$6,521
Goodwill$0$0$0$0
Intangibles$27,190$27,190$27,190$27,190
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$9,747$107$104$104
Total NC Assets$45,181$33,934$35,042$33,815
Other Assets$0$0$0$0
Total Assets$792,340$465,627$352,735$444,654
Liabilities
Payables$3,265$3,494$3,340$1,228
Short-Term Debt$1,452$1,614$1,445$1,746
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$34,784$26,017$13,825$13,554
Total Curr. Liab.$39,501$31,125$18,610$16,528
LT Debt$2,361$928$2,588$1,296
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$3,473$4,403$5,333$7,354
Total NC Liab.$5,834$5,331$7,921$8,650
Other Liabilities$0$0$0$0
Cap. Leases$3,813$928$4,033$3,042
Total Liabilities$45,335$36,456$26,531$25,178
Equity
Pref Stock$0$0$0$0
Common Stock$66$56$47$47
Retained Earnings-$1,555,224-$1,397,361-$1,255,932-$1,143,607
AOCI$3,314$3,308$1,260$1,894
Other Equity$2,298,849$1,823,168$1,580,829$1,561,142
Total Equity$747,005$429,171$326,204$419,476
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$792,340$465,627$352,735$444,654
Net Debt-$24,543-$32,272-$25,396-$36,101